Public Company List
| Ticker | Company | Lead Asset | Indication | Stage | Next Catalyst |
|---|---|---|---|---|---|
| BCAB | BioAtla Inc | CAB-AXL-ADC | Non-Small-Cell Lung Cancer | Phase 2 | 2028-09-15 |
Antibody-Drug Conjugates Biotech Companies and Upcoming Catalysts
Public company snapshots and catalyst previews organized by modality.
Upcoming Catalysts
No public catalyst rows matched this view yet.